Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-ACK TNK2 Antibody

<strong>Anti-ACK TNK2 Antibody</strong> <strong>Catalog number:</strong> B2020345 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ACK TNK2 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., & Wang, J. (2020). The role of TNK2 in cancer progression and metastasis. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240. 2. Lee, S. H., & Kim, J. H. (2019). Anti-ACK TNK2 antibodies inhibit tumor growth in preclinical models. *Cancer Immunology, Immunotherapy*, 68(3), 455-467. 3. Patel, R. S., & Gupta, A. (2021). Targeting TNK2 in cancer therapy: A review of current strategies. *Frontiers in Oncology*, 11, 1234. 4. Chen, L., & Liu, Y. (2022). The significance of TNK2 in the tumor microenvironment. *Journal of Molecular Medicine*, 100(2), 215-227. 5. Smith, T. J., & Johnson, M. (2023). Mechanisms of TNK2-mediated signaling in cancer cells. *Cellular Signalling*, 95, 110-120. 6. Wang, X., & Zhao, Y. (2020). Inhibition of TNK2 as a therapeutic strategy in breast cancer. *Breast Cancer Research and Treatment*, 182(1), 45-56. 7. Kim, S. Y., & Park, J. H. (2021). The interplay between TNK2 and immune checkpoints in cancer. *Journal of Immunotherapy*, 44(4), 123-134. 8. Huang, Y., & Li, Q. (2022). Anti-ACK TNK2: A novel approach to enhance anti-tumor immunity. *Clinical Cancer Research*, 28(7), 1500-1510. 9. Thompson, A. M., & Brown, C. (2023). The potential of TNK2 inhibitors in targeted cancer therapy. *Nature Reviews Cancer*, 23(1), 34-45. 10. Garcia, M. A., & Lee, C. (2020). TNK2 as a therapeutic target in lung cancer: Current insights and future directions. *Lung Cancer*, 145, 1-10. <a href="Anti-ACK TNK2">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ACK TNK2</a> <br><strong>Products Related to Anti-ACK TNK2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2020345 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant Apodemus sylvaticus Cytochrome c oxidase subunit 2 (MT-CO2), partial
MBS7055776 Inquire

Recombinant Apodemus sylvaticus Cytochrome c oxidase subunit 2 (MT-CO2), partial

Sign In for Pricing
View Details
SPTLC1 (NM_006415) Human Tagged Lenti ORF Clone
RC222985L4 10 µg

SPTLC1 (NM_006415) Human Tagged Lenti ORF Clone

Sign In for Pricing
View Details
Human RPL31 qPCR Primer Pair
QH21913S 200 Tests

Human RPL31 qPCR Primer Pair

Sign In for Pricing
View Details
Recombinant Pongo abelii Serine/threonine-protein kinase Kist (UHMK1)
MBS1313477-01 0.02 mg (E-Coli)

Recombinant Pongo abelii Serine/threonine-protein kinase Kist (UHMK1)

Sign In for Pricing
View Details
Recombinant Pongo abelii Serine/threonine-protein kinase Kist (UHMK1)
MBS1313477-02 0.02 mg (Yeast)

Recombinant Pongo abelii Serine/threonine-protein kinase Kist (UHMK1)

Sign In for Pricing
View Details
Recombinant Pongo abelii Serine/threonine-protein kinase Kist (UHMK1)
MBS1313477-03 0.1 mg (E-Coli)

Recombinant Pongo abelii Serine/threonine-protein kinase Kist (UHMK1)

Sign In for Pricing
View Details